Dr. Ruth Etzioni, a biostatistician in Fred Hutchinson Cancer Research Center’s Public Health Sciences Division, has received a five-year National Institutes of Health grant to advance the science of cancer surveillance by developing, validating and deploying a scalable, automated approach for identifying cancer recurrence.
Currently, the Surveillance, Epidemiology and End Results Program, or SEER, provides extensive information regarding cancer diagnosis and some data regarding primary treatment and survival, but it does not collect information on metastatic cancer recurrence. The National Cancer Institute, which oversees the SEER registries, has identified this absence as a critical gap in cancer surveillance. Metastatic breast cancer patients and advocacy organizations have also called on the NCI to fill in these data holes by counting them in.
Etzioni’s new grant will focus on filling up that glass by leveraging both medical claims and patient-reported outcomes to fill in the gaps in metastatic breast cancer recurrence data.
Read the full article about translational tumor research by Kristen Woodward at Fred Hutchinson Cancer Research Center
Interested in learning more about Diseases and Cures? Other readers at Giving Compass found the following articles helpful for impact giving related to Diseases and Cures.
Are you ready to give?
If you are ready to take action and invest in causes for Diseases and Cures, check out these Giving Funds, Charitable Organizations and Projects related to Diseases and Cures.